Adult: As pessary: 1 mg 3 hrly. Max 5 mg for 1 course.
Vaginal Cervical ripening before surgical termination of pregnancy in the first trimester
Adult: As pessary: 1 mg 3 hr before surgery.
Vaginal Pregnancy termination in the 2nd trimester
Adult: As pessary: 1 mg 3 hrly up to 5 mg per course. May give another course 24 hr after the beginning of 1st course, if necessary.
Uterine fragility related to uterine scarring (e.g. previous caesarean section or major uterine surgery), placenta praevia, unexplained vag bleeding, untreated pelvic infection.
Patient w/ COPD, asthma, CV insufficiency, elevated intraocular pressure, cervicitis or vaginitis, cervical stenosis, multiparity and twin pregnancy. May induce spontaneous abortion. Not intended for induction of labour or cervical softening at term. Severe hepatic impairment.
Symptoms: Sedation, tremor, convulsion, dyspnoea, abdominal pain and bloody diarrhoea, palpitations and bradycardia. Management: Symptomatic and supportive treatment.
May potentiate effect of oxytocin and other labour inducers/accelerators.
Description: Gemeprost is an alprostadil (prostaglandin E1) analogue. It softens and dilates the cervix and induce uterine contractions. It is believed that gemeprost mimics the process of cervical ripening initiated by prostaglandins during childbirth. Onset: W/in 3 hr. Pharmacokinetics: Absorption: Bioavailability: 12-28%. Excretion: Via urine (50% as metabolites).
G02AD03 - gemeprost ; Belongs to the class of prostaglandins. Used to induce abortion or augment labour and to minimize blood loss from the placental site.
Buckingham R (ed). Gemeprost. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 31/05/2017.Joint Formulary Committee. Gemeprost. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 31/05/2017.